University of Gothenburg
Bild
Photo of students taking a walk in one of the buildings
Photo: Johan Wingborg
Breadcrumb

About us

Sahlgrenska Academy is the Faculty of Medicine at the University of Gothenburg. We train doctors, nurses, dentists and a number of sought-after care professions.

We are open to collaborations that help us see new perspectives and find better ways to prevent and treat illness. Here you will find international research at the utmost forefront. Successful research areas include ageing, person-centred care, cancer, metabolism, neuroscience, obstetrics, odontology, vaccines, and virology.
Our research and education mainly take place on the campus that is shared with public healthcare, especially at the hospitals within Sahlgrenska University Hospital.
We are in a development phase where our main campus will be the centre for the university's activities in Life Science.
Historically our research has led to great success, for example, dental implants, beta-blockers for heart failure, and the world's most-sold pharmaceutical Losec. We are particularly proud of our Nobel laureate Arvid Carlsson, who developed his discoveries about dopamine's important role in the brain at our campus.

Facts and figures

Size

  • We have an annual turnover of SEK 3 billion.
  • We have 2,148 employees, of whom 744 are researchers and teachers.
  • Research accounts for about 75 per cent of our turnover.

Research

  • Our research has a turnover of SEK 2,250 million annually.
  • We published 136 doctoral theses and 3,632 articles in scientific journals in 2024.
  • We have 1,100 doctoral students.

Education

  • We have 15 education programs at first level, 13 at advanced level, 3 at master's level and 5 supplementary education programs for people with foreign degrees from countries outside the EU/EEA and Switzerland.
  • Our education has a turnover of SEK 850 million annually.
  • We have 5,500 students.
  • We have about 100 international agreements with other universities.

Research funding

  • We receive SEK 1 billion annually in external funds.
  • Our most prominent external financiers are, in order of size:
    • The Swedish Research Council
    • Swedish Cancer Society
    • European Union
    • Swedish Research Council for Health, Working Life and Welfare
    • Swedish Heart-Lung Foundation
    • Knut and Alice Wallenberg Foundation